Azitra

Azitra Current Ratio

The Current Ratio of Azitra (AZTR) as of Oct 21, 2026 is -0.55. In the previous year, Current Ratio was 2.34 — a change of -123.74% (lower).

Current Ratio

-0.55

YoY

-123.74%

Last updated:

Current Ratio of Azitra is 2025 -0.55 . Current Ratio of Azitra was 2024 2.34 . It decreases by -123.74% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Azitra Stock analysis

What does Azitra do? Azitra Inc., based in Branford, Connecticut, is an early-stage biopharmaceutical company focused on developing topical therapies for dermatological conditions. The company utilizes engineered proteins and live biotherapeutic products, leveraging a microbial library of 1,500 bacterial strains and AI-driven screening to create treatments for skin diseases. Its pipeline includes ATR-12 for Netherton syndrome, ATR-04 for papulopustular rash, and ATR-01 for ichthyosis vulgaris, all targeting unmet medical needs in precision dermatology. Listed on June 16, 2023, Azitra operates with a team of 10 employees. Azitra is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Azitra stock

Current Ratio of Azitra is -0.55 in 2025.

Current Ratio of Azitra changed from 2.34 to -0.55, representing a -123.74% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Azitra since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Azitra with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Azitra

All Key Metrics — Azitra